Review of docetaxel in the treatment of gastric cancer

Review of docetaxel in the treatment of gastric cancer

Eric D Tetzlaff1, Jonathan D Cheng1, Jaffer A Ajani21Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA; 2Gastrointestinal Medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USAAbstract: Gastric cancer is a global health problem accounting for 800,000 cancer related deaths ann...

Full description

Bibliographic Details
Main Authors:	Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/review-of-docetaxel-in-the-treatment-of-gastric-cancer-a2160

Similar Items

Effect of docetaxel + oxaliplatin + S-1 and docetaxel + cisplatin + fluorouracil on treatment of advanced gastric cancer
by: Wei Li, et al.
Published: (2016-09-01)

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
by: Putao Cen, et al.
Published: (2008-03-01)

Role of docetaxel in the treatment of advanced gastric carcinoma
by: Mario Scartozzi, et al.
Published: (2009-03-01)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
by: Brian Badgwell, et al.
Published: (2017-08-01)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
by: Yan Xu, et al.
Published: (2019-11-01)

Docetaxel in the treatment of hormone-resistant prostate cancer
by: B. V. Bukharkin, et al.
Published: (2020-02-01)

Comparison on Efficacy of S-1 Respectively Combined with Oxaliplatin and Docetaxel for Advanced Gastric Cancer
by: Junna Zhi, et al.
Published: (2014-03-01)

The Effect of Docetaxel (Taxotere®) on Human Gastric Cancer Cells Exhibiting Low-Dose Radiation Hypersensitivity
by: Elizabeth K. Balcer-Kubiczek Ph.D., et al.
Published: (2008-01-01)

Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting
by: N. S. Besova, et al.
Published: (2021-06-01)

Docetaxel (Tautax) in the treatment of hormone-refractory prostate cancer
by: I. G. Rusakov, et al.
Published: (2020-02-01)

Polymorphisms of <it>TGFB1 </it>and <it>VEGF </it>genes and survival of patients with gastric cancer
by: Ajani Jaffer A, et al.
Published: (2009-06-01)

Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma
by: Ying Liu, et al.
Published: (2013-01-01)

The <it>VEGF </it>-634G>C promoter polymorphism is associated with risk of gastric cancer
by: Ajani Jaffer A, et al.
Published: (2009-10-01)

Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
by: Elena Andreea Stoicescu, et al.
Published: (2021-06-01)

S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
by: Feiyu Diao, et al.
Published: (2019-10-01)

Effect of the preoperative docetaxel combined with S-1 chemotherapy on the oncogene expression in advanced gastric cancer lesion
by: E-Yi Ben, et al.
Published: (2017-11-01)

The role of docetaxel in the multimodal treatment of non-small cell lung cancer
by: Rita De Sanctis, et al.
Published: (2009-06-01)

Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
by: Yoshida Kazuhiro, et al.
Published: (2010-05-01)

An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer
by: S. Thambiraj, et al.
Published: (2021-02-01)

Clinical Study of Docetaxel, Prednisone and Bevacizunab in the Treatment of Hormone Refractory Prostate Cancer
by: Theodore D. Koreckij, et al.
Published: (2015-06-01)

Effects of docetaxel combined with platinum drugs and S-1 chemotherapy on cancer cell growth in advanced gastric cancer lesions
by: Xiong Zhang, et al.
Published: (2017-06-01)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019-12-01)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
by: Victoria J Sinibaldi
Published: (2008-01-01)

Overcoming docetaxel resistance in prostate cancer: a perspective review
by: Clara Hwang MD
Published: (2012-11-01)

Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1
by: Joo Young Jung, et al.
Published: (2016-01-01)

Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
by: Liu Y, et al.
Published: (2016-03-01)

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
by: S. Aishah A. Razak, et al.
Published: (2021-01-01)

Effects of bisphosphonates alone and in combination with docetaxel : Studies in Prostate Cancer
by: Coxon, Jonathan Philip
Published: (2007)

Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroids
by: John W. Roman, MD, et al.
Published: (2017-07-01)

Monotherapy with docetaxel in treatment of hormone resistant cancer of the prostate - our results
by: N K Mohanty, et al.
Published: (2003-01-01)

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation
by: Reka Varnai, et al.
Published: (2019-08-01)

Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
by: Ietsen de Groot, et al.
Published: (2021-11-01)

Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer
by: Tae Woo Kim, et al.
Published: (2017-10-01)

Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study
by: M. Berkut, et al.
Published: (2020-11-01)

ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
by: Yangkai Li, et al.
Published: (2013-01-01)

Undifferentiated prostate cancer treated with docetaxel
by: Masaki Kobayashi, et al.
Published: (2020-07-01)

The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance
by: Lorenzo Bascetta, et al.
Published: (2017-07-01)

Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
by: Ling-Cheng Wang MD, et al.
Published: (2020-06-01)

Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
by: Hu Y, et al.
Published: (2020-12-01)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
by: Filippo Francini, et al.
Published: (2011-01-01)

Cannot write session to /tmp/vufind_sessions/sess_08g2qtrhovtsdgrikfr8vs21n9